XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.1
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 585.4 $ 610.8    
Cost of goods sold 279.4 284.9    
Deferred Revenue 68.1   $ 61.5  
Retained earnings 7,480.4   7,416.4  
Accumulated other comprehensive loss (409.8)   (538.2)  
Total stockholders' equity $ 6,679.4 9,051.3 6,569.3 $ 8,741.2
Revenue Allocation Percent To Lease Elements 3.00%      
Additional paid-in-capital $ 475.7   463.2  
Selling, general and administrative expense 208.8 214.9    
Research and Development Expense 73.5 66.4    
Interest expense 12.0 12.3    
Other Nonoperating Income (Expense) 37.2 34.6    
Deferred Revenue, Current 53.8   $ 47.8  
Europe [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 199.8 200.2    
Asia Pacific [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 104.1 117.2    
UNITED STATES        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 241.7 252.9    
Americas [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 39.8 $ 40.5